Are you Dr. Hess?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 62 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
171 Ashley Ave
Charleston, SC 29425Phone+1 843-792-1414
Summary
- Dr. Brian Hess, MD is an oncologist in Charleston, South Carolina. He is currently licensed to practice medicine in South Carolina, Missouri, and Illinois. He is affiliated with MUSC Health University Medical Center.
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2013 - 2016
- Loyola University Medical CenterResidency, Internal Medicine, 2010 - 2013
- University of Missouri-Columbia School of MedicineClass of 2010
Certifications & Licensure
- SC State Medical License 2016 - 2025
- MO State Medical License 2014 - 2017
- IL State Medical License 2010 - 2014
Publications & Presentations
PubMed
- 6 citationsA multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma.Yazeed Sawalha, Subir Goyal, Jeffrey M Switchenko, Jason T Romancik, Manali Kamdar
Blood Advances. 2023-07-11 - 4 citationsImpact of race and social determinants of health on outcomes in patients with aggressive B-cell NHL treated with CAR-T therapy.Reem Karmali, Rushad Machhi, Narendranath Epperla, Geoffrey Shouse, Jason Romancik
Blood Advances. 2024-05-28 - 52 citationsCorrelations Between Ratings on the Resident Annual Evaluation Summary and the Internal Medicine Milestones and Association With ABIM Certification Examination Scores ...Karen E. Hauer, Jonathan L. Vandergrift, Brian J. Hess, Rebecca S. Lipner, Eric S. Holmboe
JAMA. 2016-12-06
Press Mentions
- Medical Student Carries Her Lymphoma Experience with HerMarch 15th, 2023
- Pre-Exposure Prophylaxis with Tixagevimab-Cilgavimab Protects Blood Cancer Patients Against COVIDDecember 16th, 2022
- Oncologist Leaves a Lasting Legacy at MUSC Hollings Cancer CenterJune 23rd, 2021